Using its single molecule detection and quantification capabilities, SMi has been contracted to develop a novel quality control assay for biologics production.
Read More
SMi announces its appointment of two new research scientists to expand its laboratory talent.
Read More
The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics.
Read More
SMi is delighted to be named as a finalist for the Best New Business award. The ceremony is due to take place on 28th September 2023.
Read More
Medicines Discovery Catapult and SMi’s CEO describe what has made their partnership so successful.
Read More
Medicines Discovery Catapult features the success of SMi’s partnerships to develop diagnostics for cancer and infectious disease.
Read More
Investment enables development of revolutionary multi-omic platform using super-resolution imaging technology for earlier disease detection and accelerated discovery of therapeutics.
Read More
The University of Cambridge has released a press article detailing SMi’s revolutionary diagnostic technology.
Read More
SMi has been shortlisted for two awards, ‘The One to Watch’ and ‘Medtech Company of the Year.’ The ceremony is to be held on 18th May 2023.
Read More